Coverage of prandial insulin requirements by means of an ultra-rapid-acting inhaled insulin.
about
Inhaled insulin: A "puff" than a "shot" before mealsImproving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator.In silico assessment of biomedical products: The conundrum of rare but not so rare events in two case studies.A Population Dose-Response Model for Inhaled Technosphere Insulin Administered to Healthy Subjects.Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?Role of Emerging Insulin Technologies in the Initiation and Intensification of Insulin Therapy for Diabetes in Primary Care.Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming.Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled InsulinUltrafast-acting insulins: state of the artMethods to enhance delivery of prandial insulin and basal-prandial insulin.Moving toward the ideal insulin for insulin pumps.Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.Inhaled Insulin - Current Direction of Insulin ResearchThe Need for Faster Insulin.Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): a 52-week, randomized, treat-to-target, phase 3 trial.
P2860
Q26796644-AFF21CC1-CCA1-4CA0-AD70-6E730F4DF784Q27307805-149F05FF-9F4E-4745-9505-FFE00DAB296AQ30252581-16A6CFEB-C9CC-4BD6-BD53-BBB52153BA54Q33845504-51F1F114-0BA3-42A4-896C-11C7D184D570Q34533154-B691C2E7-81E5-48D4-BE2B-B90121CB9E03Q36467597-7F8FC7B4-856E-4168-8233-F63C593380D9Q37460129-B4B37002-CC40-4906-9E1A-A2023F03E108Q37732207-EE4650C5-2E45-49C6-B402-90B426A4AB16Q38037727-6B1FF6F4-9E8F-47C8-BDA6-7E51B6EB81E9Q38085333-229EFF04-F81E-45EE-A8EB-F36D409560DFQ38631154-64132C6D-A5A6-4AB3-B793-E17875F29203Q39087090-9A37518F-C503-4FC9-A509-F998BCDF5253Q39344293-27BD370B-572C-471E-B497-51A961EFAEABQ43143808-318F6984-E692-40DF-9AA2-0A31ECC303C1Q47188954-FFB9978F-BA6C-43BE-B20E-1D6C2D0BE39A
P2860
Coverage of prandial insulin requirements by means of an ultra-rapid-acting inhaled insulin.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Coverage of prandial insulin r ...... -rapid-acting inhaled insulin.
@ast
Coverage of prandial insulin r ...... -rapid-acting inhaled insulin.
@en
type
label
Coverage of prandial insulin r ...... -rapid-acting inhaled insulin.
@ast
Coverage of prandial insulin r ...... -rapid-acting inhaled insulin.
@en
prefLabel
Coverage of prandial insulin r ...... -rapid-acting inhaled insulin.
@ast
Coverage of prandial insulin r ...... -rapid-acting inhaled insulin.
@en
P2093
P2860
P1476
Coverage of prandial insulin r ...... -rapid-acting inhaled insulin.
@en
P2093
Anders H Boss
Daniel Lorber
Richard Petrucci
P2860
P304
P356
10.1177/193229681200600406
P577
2012-07-01T00:00:00Z